Collegium Pharmaceutical, Inc. (COLL)

45.60 -1.30 (-2.77%) USD  |  NASDAQ  |  Jan 16, 16:00
45.60 0.00 (0.00%) After-Hours: 20:00
More

Collegium Pharmaceutical Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. --
Intuitive Surgical, Inc. Upgrade
Hims & Hers Health, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade